The Harvard Hedge Fund?

A blog post by Matthew Yglesias ’03 has sparked quite a lively debate about whether Harvard deserves its tax-exempt status...

A blog post by Matthew Yglesias ’03 has sparked quite a lively debate about whether Harvard deserves its tax-exempt status. This is all a response to a bill being debated in the Massachusetts legislature to tax college endowments exceeding $1 billion.

Yglesias, a blogger for TheAtlantic.com, starts by quoting another blogger's comparison of Harvard's endowment to "a $40 billion tax-free hedge fund with a very large marketing and PR arm called Harvard University." Comments from site visitors draw in a cornucopia of related issues: tuition, financial aid, admissions policies, the general role of elite universities in society.

You can even add your two cents if you scroll down to the bottom of the page.

Related topics

You might also like

A History of Harvard Magazine

Harvard’s independent alumni magazine—at 127 years old 

Your Views on Conservatism on Campus, Doxxing, and More

Readers write in about international students at Harvard, the September-October cover, and changes at the Chan School of Public Health.

Most popular

Harvard Students, Alumna Named Rhodes and Marshall Scholars

Nine Rhodes and five Marshall scholars will study in the U.K. in 2026.

Zelia Nuttall

Brief life of a remarkable anthropologist (1857-1933)

Explore More From Current Issue

Map showing Uralic populations in Eurasia, highlighting regional distribution and historical sites.

The Origins of Europe’s Most Mysterious Languages

A small group of Siberian hunter-gatherers changed the way millions of Europeans speak today.

Three book covers displayed on a light background, featuring titles and authors.

Must-Read Harvard Books Winter 2025

From aphorisms to art heists to democracy’s necessary conditions 

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.